Total Payments
$1,215
2024 Payments
$99.99
Companies
6
Transactions
19
Medicare Patients
801
Medicare Billing
$159,068
Payment Breakdown by Category
Food & Beverage$957.66 (78.8%)
Education$256.98 (21.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $957.66 | 16 | 78.8% |
| Education | $256.98 | 3 | 21.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $683.36 | 7 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $263.81 | 8 | $0 (2018) |
| Alkermes, Inc. | $84.17 | 1 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $81.94 | 1 | $0 (2019) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $73.50 | 1 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $27.86 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $99.99 | 1 | Teva Pharmaceuticals USA, Inc. ($99.99) |
| 2022 | $85.50 | 1 | Teva Pharmaceuticals USA, Inc. ($85.50) |
| 2021 | $71.49 | 1 | Teva Pharmaceuticals USA, Inc. ($71.49) |
| 2020 | $27.86 | 1 | Sunovion Pharmaceuticals Inc. ($27.86) |
| 2019 | $201.94 | 2 | Teva Pharmaceuticals USA, Inc. ($120.00) |
| 2018 | $399.77 | 9 | Teva Pharmaceuticals USA, Inc. ($186.38) |
| 2017 | $328.09 | 4 | Otsuka America Pharmaceutical, Inc. ($123.92) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/29/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $99.99 | General |
| 09/22/2022 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $85.50 | General |
| 08/25/2021 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $71.49 | General |
| 05/28/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: CNS | ||||||
| 03/21/2019 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $81.94 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Central Nervous System | ||||||
| 12/04/2018 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $73.50 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $5.48 | General |
| Category: PSYCHIATRY | ||||||
| 10/13/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $96.20 | General |
| Category: Central Nervous System | ||||||
| 08/31/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $3.27 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: PSYCHIATRY | ||||||
| 07/27/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: PSYCHIATRY | ||||||
| 07/20/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $4.02 | General |
| Category: PSYCHIATRY | ||||||
| 05/18/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $2.76 | General |
| Category: PSYCHIATRY | ||||||
| 05/12/2018 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $90.18 | General |
| Category: Central Nervous System | ||||||
| 12/12/2017 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Central Nervous System | ||||||
| 09/15/2017 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $3.92 | General |
| Category: PSYCHIATRY | ||||||
| 09/05/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $84.17 | General |
| Category: CNS | ||||||
| 05/10/2017 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 129 | 402 | $133,411 | $33,442 |
| 2022 | 4 | 145 | 460 | $152,050 | $39,437 |
| 2021 | 6 | 212 | 577 | $186,292 | $49,119 |
| 2020 | 8 | 315 | 589 | $140,280 | $37,070 |
Total Patients
801
Total Services
2,028
Medicare Billing
$159,068
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 81 | 339 | $111,870 | $28,339 | 25.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 25 | 25 | $12,725 | $3,101 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 38 | $8,816 | $2,001 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 384 | $126,720 | $32,804 | 25.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 21 | 21 | $10,689 | $2,467 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 36 | $8,352 | $2,263 | 27.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 11 | 19 | $6,289 | $1,903 | 30.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 102 | 417 | $137,610 | $37,298 | 27.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 28 | 28 | $14,252 | $4,125 | 28.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 22 | 50 | $16,550 | $3,869 | 23.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 57 | $13,224 | $2,905 | 22.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 11 | 12 | $2,784 | $627.29 | 22.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 11 | 13 | $1,872 | $293.57 | 15.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 91 | 266 | $75,544 | $17,507 | 23.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 41 | 70 | $10,922 | $5,743 | 52.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 68 | 121 | $23,474 | $5,164 | 22.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 35 | 36 | $14,436 | $3,258 | 22.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 31 | 42 | $4,211 | $2,216 | 52.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 14 | 18 | $6,840 | $2,103 | 30.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 15 | 16 | $3,024 | $923.12 | 30.5% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 20 | 20 | $1,829 | $156.01 | 8.5% |
About Dr. Harold Whiteley, M.D
Dr. Harold Whiteley, M.D is a Psychiatry healthcare provider based in Eugene, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942278817.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harold Whiteley, M.D has received a total of $1,215 in payments from pharmaceutical and medical device companies, with $99.99 received in 2024. These payments were reported across 19 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($957.66).
As a Medicare-enrolled provider, Whiteley has provided services to 801 Medicare beneficiaries, totaling 2,028 services with total Medicare billing of $159,068. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Eugene, OR
- Active Since 03/08/2006
- Last Updated 07/16/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1942278817
Products in Payments
- AUSTEDO (Drug) $426.38
- REXULTI (Drug) $337.31
- Aristada 441 mg (Drug) $84.17
- TRINTELLIX (Drug) $81.94
- LATUDA (Drug) $27.86
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Eugene
Dr. John Lipkin, M.d, M.D
Psychiatry — Payments: $15,260
Psychiatry $15,260
Dr. Hernan Schmidt, M.d, M.D
Psychiatry — Payments: $6,567
Psychiatry $6,567
Victor Richenstein, Md, MD
Psychiatry — Payments: $5,106
Psychiatry $5,106
Veronica Alfero, Md, MD
Psychiatry — Payments: $2,017
Psychiatry $2,017
Dr. Franc Strgar, M.d, M.D
Psychiatry — Payments: $1,445
Psychiatry $1,445
Dr. Russell Geoffrey, Md, MD
Psychiatry — Payments: $1,378
Psychiatry $1,378